Please Subscribe to get a daily link to Pat's blog via email


Your privacy is important to us. We will never spam you and keep your personal data secure.


18 11, 2014

Early myeloma related ASH announcements

Tags: , , , , , |5 Comments

I've very excited!  Yesterday my registration materials arrived for next month's American Society of Hematology (ASH) annual meetings in San Francisco.  And like clockwork, researchers and pharmaceutical companies have started issuing press releases promoting presentations featuring clinical trial results to be presented there. Here are two early examples.  Keep in mind that a lot new

17 10, 2011

Explore using uncommon alternatives if Revlimid and Velcade aren’t working…

Tags: , , , , |0 Comments

Here is a LINK to a story the Myeloma Beacon ran late last week about a European study, featuring an existing cancer drug, bendamustine (trade name:  Treanda). Like a dozen other experimental drugs, bendamustine shows promise against multiple myeloma. The difference is, this drug may work in patients with few if any remaining options. And